Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00118443 · ClinicalTrials.gov registry record · Phase 2
Evaluation of a School-Based Training Program for Suicide Prevention
A Phase 2 study of Suicide, sponsored by University of Rochester.
- Completed
- Registry status
- Phase 2
- Development phase
- 50,000
- Enrollment target
- 1
- Study location
NCT00118443: Completed Phase 2 study of Suicide, sponsored by University of Rochester.
NCT00118443 is a Phase 2 study of Suicide that has completed, run by University of Rochester. The registered enrollment target is 50,000 participants, above the 6,446-participant average among 92 other Suicide trials with a reported enrollment target (676% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00118443, a Phase 2 study of Suicide, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 50,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will determine whether a training program designed to help school staff members identify adolescents at risk for suicide will increase the number of students who are referred to mental health services.
Conditions Studied
Interventions
- BEHAVIORAL Question, Persuade, Refer (QPR) training
Study Locations (1)
Georgia
- Cobb County School District - Marietta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50,000 participants |
| Start Date | 2004-03 |
| Est. Completion | 2006-12 |
| Phase | Phase 2 |
What the finished NCT00118443 record still lists
NCT00118443 is an interventional study that assigns participants to a tested intervention. Its 50,000 participants enrollment target places it among the larger protocols in the corpus, above the 6,446-participant average among 92 other Suicide trials with a reported enrollment target (676% higher).
The record links to 1 condition, with Suicide appearing as the primary indexed condition, and to 1 intervention - of which Question, Persuade, Refer (QPR) training is the first listed.
NCT00118443 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT00118443 about?
NCT00118443 is a clinical study titled "Evaluation of a School-Based Training Program for Suicide Prevention". This study will determine whether a training program designed to help school staff members identify adolescents at risk for suicide will increase the number of students who are referred to mental health services.
What is the current status of trial NCT00118443?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 50,000 participants. The study started on 2004-03. Estimated completion is 2006-12.
What conditions does trial NCT00118443 study?
This clinical trial studies the following conditions: Suicide.
What interventions are being tested in trial NCT00118443?
The interventions under investigation include: Question, Persuade, Refer (QPR) training (BEHAVIORAL).
Who is sponsoring clinical trial NCT00118443?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00118443 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicide
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00118443's enrollment target sits among peer trials
50,000 3rd of 92 higher than 90 of 92 other Suicide trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Suicide trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Suicide Risk Interventions
RECRUITING · Phase 2
-
Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression
RECRUITING · Phase 2
-
Ketamine & Crisis Response Plan for Suicidal Ideation in the ED
RECRUITING · Phase 2
-
Computerized Cognitive Behavioral Therapies for Suicide Prevention and Depression
RECRUITING · Phase 2
-
Safe Treatment for Emergency Presentation for Suicidal Ideation and Behavior in Youth
RECRUITING · Phase 2
-
Developing an Intervention to Promote Lethal Means Safety in Suicidal Adolescents
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00500123 · 50,000 participants
The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study
- NCT01885299 · 50,000 participants
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
- NCT03452774 · 50,000 participants
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- NCT04629586 · 50,000 participants
The T1D Exchange Registry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia